Boitumelo Semete-Makokotlela
Boitumelo Semete-Makokotlela is the CEO of the South African Health Products Regulatory Authority, recently mentioned in the context of overseeing the registration process for new HIV prevention medications in South Africa amidst ongoing challenges with Pepfar funding.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| South Africa | 1 | 7.00 | 0.51% | +0% | 59,308,690 | 302,595 | $350,000 | 1,786$ |
| Totals | 1 | 59,308,690 | 302,595 | $350,000 | 1,786$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
South Africa:
Boitumelo Semete-Makokotlela is the chief executive of the South African Health Products Regulatory Authority.
7
South Africa:
Boitumelo Semete-Makokotlela is the chief executive of Sahpra, who discussed the risks of unregulated ketamine use.
6
South Africa:
Boitumelo Semete-Makokotlela is the chief executive of Sahpra and is open to the rescheduling of scheduled substances.
7
South Africa:
Boitumelo Semete-Makokotlela is the CEO of the South African Health Products Regulatory Authority.
5
South Africa:
Boitumelo Semete-Makokotlela is the CEO of Sahpra, involved in the registration of lenacapavir.
5